Ochs H R, Verburg-Ochs B, Höller M, Greenblatt D J
J Cardiovasc Pharmacol. 1985 Jan-Feb;7(1):205-7. doi: 10.1097/00005344-198501000-00032.
The influence of the serotonin antagonist ketanserin on the kinetics of digoxin and digitoxin were evaluated in healthy volunteers. Subjects received a single intravenous dose of digoxin (1.25 mg) or of digitoxin (1.0 mg) on two occasions: once in the control state, and again during treatment with ketanserin, 40 mg twice daily. Ketanserin caused a prolongation of digoxin elimination half-life (50 versus 40 h) and reduction in clearance (2.4 versus 3.7 ml/min/kg), but differences were not significant. For digitoxin, ketanserin caused a small but significant (p less than 0.005) increase in volume of distribution (0.89 versus 0.78 L/kg), but no significant effect on half-life (7.0 versus 6.8 days), or clearance (0.063 versus 0.059 ml/min/kg). Thus, ketanserin coadministration is not likely to alter steady-state concentrations of digoxin or digitoxin during clinical use of these two digitalis glycosides.
在健康志愿者中评估了5-羟色胺拮抗剂酮色林对地高辛和洋地黄毒苷动力学的影响。受试者分两次接受单次静脉注射地高辛(1.25毫克)或洋地黄毒苷(1.0毫克):一次在对照状态下,另一次在酮色林治疗期间,每日两次,每次40毫克。酮色林使地高辛消除半衰期延长(50小时对40小时),清除率降低(2.4毫升/分钟/千克对3.7毫升/分钟/千克),但差异不显著。对于洋地黄毒苷,酮色林使分布容积有小幅度但显著的增加(0.89升/千克对0.78升/千克)(p小于0.005),但对半衰期(7.0天对6.8天)或清除率(0.063毫升/分钟/千克对0.059毫升/分钟/千克)无显著影响。因此,在临床使用这两种洋地黄糖苷期间,合用酮色林不太可能改变地高辛或洋地黄毒苷的稳态浓度。